GlassScriptPhysician profile
Edward J Ha
NPI 1588762504
$3,315.85
in general payments reported to CMS, 2019-2025
19 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $373 · 2021: $60.63 · 2022: $310 · 2023: $255 · 2024: $305 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,215.58 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Ingevity Mri |
| Janssen Pharmaceuticals, INC | $278.29 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $274.55 | 2019-2023 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.31 | 2019-2023 | Lifevest |
| Abbott Laboratories | $219.53 | 2024-2025 | Cardiomems, Aveir |
| Novartis Pharmaceuticals Corporation | $208.80 | 2019-2023 | |
| Amarin Pharma, INC. | $152.12 | 2019-2020 | |
| Amgen INC. | $151.80 | 2019-2023 | Repatha |
| Medtronic, INC. | $124.99 | 2025 | Corevalve Evolut R |
| Shockwave Medical, INC | $97.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $69.48 | 2019-2022 | |
| Edwards Lifesciences Corporation | $60.27 | 2019 | |
| Pfizer INC. | $55.27 | 2019-2023 | |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Sanofi-Aventis U.S. LLC | $46.25 | 2019-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31.68 | 2025 | Wegovy |
| Atricure, INC. | $26.50 | 2019 | |
| Philips North America LLC | $14.45 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.